Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2627 stock hub

HKG/2627 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2627is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.5B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2627

In the news

Latest news · HKG/2627

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROEn/a

P25 -14.7P50 2P75 9.4

ROICn/a

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2627 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

142

Groups with data

Currency

CNY

Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	583
Enterprise value	HKD 12.4B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000071P9
Last refreshed	2026-05-10
Market cap	HKD 11.5B
Price	HKD 29.32
Price currency	HKD
Rev Per Employee	608,518.87x
Sector	Healthcare
Sic	2834
Symbol	hkg/2627
Website	https://www.abbbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.13%
EV Earnings	-50.51x
EV/FCF	-49.48x
EV/Sales	35.01x
FCF yield	-2.18%
P/B ratio	312.78x
P/S ratio	32.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-62.61%
EBITDA Margin	-45.07%
Gross margin	67.29%
Gross Profit	HKD 238.7M
Net Income	HKD -245.9M
Net Income Growth Years	1%
Pretax Margin	-69.32%
Profit Margin	-69.32%
Profit Per Employee	HKD -421,823
ROCE	-33.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	1
Revenue Growth	397.65x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	HKD 1.6B
Cash	HKD 118.8M
Current Assets	HKD 437.2M
Current Liabilities	HKD 990.2M
Debt	HKD 1B
Debt Equity	HKD 27.23
Debt FCF	HKD -4
Equity	HKD 36.9M
Interest Coverage	-10.02
Liabilities	HKD 1.6B
Long Term Assets	HKD 1.2B
Long Term Liabilities	HKD 570.1M
Net Cash	HKD -885.5M
Net Cash By Market Cap	HKD -7.68
Net Debt Equity	HKD 24.01
Tangible Book Value	HKD 29.5M
Tangible Book Value Per Share	HKD 0.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.44
Net Working Capital	HKD -200.8M
Quick ratio	0.32
Working Capital	HKD -526.3M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	48.02
All Time High	73
All Time High Change	-59.84%
All Time High Date	2026-03-11
All Time Low	28.88
All Time Low Change	1.52%
All Time Low Date	2026-03-31
ATR	5.04
Beta1y	1.11
Ch YTD	-27.14
High	30.46
High52	73
High52 Date	2026-03-11
High52ch	-59.84%
Low	28.88
Low52	28.88
Low52 Date	2026-03-31
Low52ch	1.52%
Ma50ch	-38.94%
RSI	30.43
RSI Monthly	0
RSI Weekly	32.07
Sharpe ratio	0.13x
Sortino ratio	0.28
Tr YTD	-27.14
Tr1m	-42.79%
Tr1w	-14.87%
Tr3m	-26.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -222.1M
Operating margin	-62.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	137,627,993%
Net Borrowing	191,764,037.1
Shares Insiders	32.79%
Shares Institutions	37.44%
Shares Out	393,442,600
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD -296.7M
Average Volume	1,390,071.1x
Bv Per Share	0.1
CAPEX	HKD -115.7M
Ch1m	-42.79
Ch1w	-14.87
Ch3m	-26.74
Ch6m	-40.53
Change	-1.01%
Change From Open	-2.2
Close	29.62
Days Gap	1.22
Depreciation Amortization	65,382,295.4
Dollar Volume	3,723,640
Earnings Date	2026-05-28
EBIT	HKD -222.1M
EBITDA	HKD -159.9M
EPS	HKD -0.68
F Score	1
FCF	HKD -251M
FCF EV Yield	-2.02x
FCF Per Share	HKD -0.64
Financing CF	167,563,417
Fiscal Year End	December
Founded	2,015
Investing CF	-112,517,996
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-06-30
Ma150	45.5
Ma150ch	-35.55%
Ma20	44.47
Ma20ch	-34.07%
Net CF	-80,250,557
Next Earnings Date	2026-05-28
Open	29.98
Position In Range	27.85
Ppne	1,140,534,532.1
Price Date	2026-03-31
Ptbv Ratio	390.6
Relative Volume	0.09x
Revenue	354,766,501x
SBC By Revenue	12.87x
Share Based Comp	45,656,777
Tr6m	-40.53%
Volume	127,000
Z Score	-1.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2627 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns HKG/2627?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.4%

Share of float held by funds and institutions

Insider ownership

+32.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/2627 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.4

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2627

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2627 stock rating?

hkg/2627 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2627 analysis?

The full report lives at /stocks/hkg/2627/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2627?

The latest report frames hkg/2627 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2627 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.